Exploratory study of AC-262271 in patients with glaucoma
Latest Information Update: 12 May 2016
At a glance
- Drugs AC 262271 (Primary)
- Indications Glaucoma
- Focus Adverse reactions
- Sponsors Allergan
Most Recent Events
- 12 May 2016 New trial record
Latest Information Update: 12 May 2016